AU6199100A - Cloning and expressing of human cathepsin k in mammalian cells - Google Patents

Cloning and expressing of human cathepsin k in mammalian cells

Info

Publication number
AU6199100A
AU6199100A AU61991/00A AU6199100A AU6199100A AU 6199100 A AU6199100 A AU 6199100A AU 61991/00 A AU61991/00 A AU 61991/00A AU 6199100 A AU6199100 A AU 6199100A AU 6199100 A AU6199100 A AU 6199100A
Authority
AU
Australia
Prior art keywords
cloning
expressing
mammalian cells
human cathepsin
cathepsin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61991/00A
Other languages
English (en)
Inventor
Cheryl Schaffer Brehme
Timothy Hill
Steven J. Roman
Mohammad S Saedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of AU6199100A publication Critical patent/AU6199100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU61991/00A 1999-06-25 2000-06-15 Cloning and expressing of human cathepsin k in mammalian cells Abandoned AU6199100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34422899A 1999-06-25 1999-06-25
US09344228 1999-06-25
PCT/US2000/016502 WO2001000798A2 (fr) 1999-06-25 2000-06-15 Clonage et expression de cathepsine k humaine dans des cellules mammaliennes

Publications (1)

Publication Number Publication Date
AU6199100A true AU6199100A (en) 2001-01-31

Family

ID=23349595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61991/00A Abandoned AU6199100A (en) 1999-06-25 2000-06-15 Cloning and expressing of human cathepsin k in mammalian cells

Country Status (2)

Country Link
AU (1) AU6199100A (fr)
WO (1) WO2001000798A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005093421A1 (fr) * 2004-03-10 2005-10-06 Biovendor Laboratory Medicine, Inc. Dosage immuno-enzymatique pour mettre en evidence la cathepsine k

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
US6544767B1 (en) * 1994-10-27 2003-04-08 Axys Pharmaceuticals, Inc. Cathespin O2 protease
WO1997047642A1 (fr) * 1996-06-14 1997-12-18 Smithkline Beecham Corporation Gene de la cathepsine k

Also Published As

Publication number Publication date
WO2001000798A2 (fr) 2001-01-04
WO2001000798A3 (fr) 2001-08-09
WO2001000798A9 (fr) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2569599A (en) Cells or tissues with increased protein factors and methods of making and using same
AU1834197A (en) Cells expressing both human cd4 and cxcr4
AU2001273151A1 (en) Human extracellular matrix and cell adhesion polypeptides
HUP0201474A2 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
AU1926001A (en) Novel human protein kinases and protein kinase-like enzymes
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
AU2002357079A1 (en) Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase
AU8140998A (en) Development and use of human pancreatic cell lines
AU2786100A (en) Method of selecting transformed cells and tissues
AU2002335104A1 (en) Induction of beta cell differentiation in human cells
AU2002221755A1 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
AU3501700A (en) Human endokine alpha and methods of use
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001217686A1 (en) Method of establishing cultures of human dendritic cells and use thereof
AU6199100A (en) Cloning and expressing of human cathepsin k in mammalian cells
AU2002309989A1 (en) Directed evolution of protein in mammalian cells
AU2998300A (en) Genetically altered mesenchymal stem cells and methods of use thereof
AU2001289806A1 (en) Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations
AU2001256448A1 (en) Cell and tissue culturing unit with variable configuration
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
PL352326A1 (en) Noval vegetable genes and use of same
AU4774200A (en) Long term cell culture of human carcinoma
IL145056A0 (en) Expression of human alpha-fetoprotein in mammalian cells
AU4459100A (en) Cell cycle genes and methods of use
AU2392300A (en) Use of essential (saccharomyces) genes and polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase